Clinical Trial

Observational Registry of Transoral Incisionless Fundoplication (TIF) for Gastroesophageal Reflux Disease (GERD)

Study acronym: TIF/2021
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 4, 2021 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational registry aims to: 1) record the TIF interventions in patients with esophageal or extra-esophageal symptoms; 2) to monitor the therapy response through the clinical experience in terms of effect on the use and dosage of proton pump inhibitors (PPIs) and on the GERD-Health Related Quality of Life (HRQL) and Reflux Symptom Index (RSI) questionnaires scores; 3) to characterize the treated patients population and the predictive factors of TIF success, identifying the subpopulation who may effectively benefit from TIF.
Trial Details
NCT Number NCT05066594
Lead Sponsor IRCCS San Raffaele
Conditions Gastro Esophageal Reflux
Enrollment 100 participants
Start Date 2021-05-01
Primary Completion 2026-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2021-10-04